Akili Enhances Board and Announces Financial Results
Company Announcements

Akili Enhances Board and Announces Financial Results

Akili (AKLI) has released an update.

Akili, Inc. has strengthened its corporate governance by appointing John Spinale as a Class I director on its board, a move that bolsters the board’s independence in line with SEC and Nasdaq requirements. Spinale, who will serve on the Audit Committee, is set to receive both cash and equity compensation under the company’s policy for non-employee directors, including stock options for common stock. His term will extend until the 2026 annual stockholders meeting, and he has entered into a standard indemnification agreement with the company. This strategic appointment comes alongside Akili’s announcement of their financial results release for the fourth quarter and full year of 2023.

For further insights into AKLI stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAkili’s Acquisition by Virtual Therapeutics and Nasdaq Delisting
TheFlyAkili announces FDA authorization of EndeavorOTC
TipRanks Auto-Generated NewsdeskAkili Announces Merger Agreement and Recommends Shareholder Approval
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!